Macrophage immunomodulatory activity of the polysaccharides from the roots of Bupleurum smithii var. parvifolium.
OBJECTIVE
Radix Bupleuri, one of the most frequently prescribed crude herbs in traditional Chinese medicine, has been used for centuries to treat inflammatory diseases. However, little is known about the therapeutic mechanisms of crude polysaccharides (BPs) isolated from the roots of Bupleurum smithii var. parvifolium. Macrophages play important roles in inflammatory diseases such as systemic lupus erythematosus (SLE). The purpose of the present work was to investigate immunomodulative effects of Bupleurum polysaccharides on murine peritoneal macrophages.


METHODS
BALB/c mice were administered intragastrically with Bupleurum polysaccharides 20, 40, and 80 mg kg(-1) day(-1), or prednisone 3 mg kg(-1) day(-1) or levamisole 25 mgk g(-1) day(-1) from day 0 to day 6. Peritoneal macrophages were isolated 5 days after intraperitoneal injection of 1 mL 5% sodium thioglycollate. Phagocytic functions of macrophages were studied; cytokines concentrations in the culture supernatants were determined by enzyme-linked immunosorbent assay and the secretion of nitric oxide (NO) was quantified by Griess reaction.


RESULTS
Treatment with BPs enhanced phagocytic functions of macrophages (phagocytosis of apoptotic thymocytes, IgG-opsonized sheep red blood cells and chicken red blood cells) and inhibited LPS-induced productions of NO and proinflammatory cytokines (interleukin-1beta, interleukin-6 and tumor necrosis factor-alpha).


CONCLUSIONS
Bupleurum polysaccharides up-regulated phagocytic activities but inhibited LPS-induced productions of proinflammatory mediators. These data suggested that at least part of the traditional beneficial effects of Bupleurum on inflammatory diseases could be ascribed to the immunomodulatory effects of Bupleurum polysaccharides on macrophages.
Cheng
Xiao-Qin
XQ
Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai, China.
Li
Hong
H
Yue
Xi-Ling
XL
Xie
Jun-Yun
JY
Zhang
Yun-Yi
YY
Di
Hong-Ye
HY
Chen
Dao-Feng
DF
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D029972:Bupleurum; D002478:Cells, Cultured; D002645:Chickens; D016207:Cytokines / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004797:Enzyme-Linked Immunosorbent Assay; D007155:Immunologic Factors / Q000494:pharmacology*; D018836:Inflammation Mediators / Q000378:metabolism; D017737:Macrophages, Peritoneal / Q000187:drug effects* / Q000276:immunology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D009569:Nitric Oxide / Q000378:metabolism; D010587:Phagocytosis / Q000187:drug effects; D010936:Plant Extracts / Q000494:pharmacology*; D011134:Polysaccharides / Q000494:pharmacology*; D012756:Sheep
D000893:Anti-Inflammatory Agents; C051274:Bupleurum root extract; D016207:Cytokines; D007155:Immunologic Factors; D018836:Inflammation Mediators; D010936:Plant Extracts; D011134:Polysaccharides; D009569:Nitric Oxide